Show simple item record

dc.contributor.advisorMeegan, Mary Jane
dc.contributor.authorButler, Stephen G.
dc.date.accessioned2016-11-28T16:38:08Z
dc.date.available2016-11-28T16:38:08Z
dc.date.issued2005
dc.identifier.citationStephen G. Butler, 'Studies in the design and synthesis of novel selective serotonin reuptake inhibitors', [thesis], Trinity College (Dublin, Ireland). School of Pharmacy & Pharmaceutical Sciences, 2005, pp 330
dc.identifier.otherTHESIS 7390
dc.identifier.urihttp://hdl.handle.net/2262/77897
dc.description.abstractThe serotonin transporter (SERT) has been the target of several modern day antidepressants with the focus on achieving selectivity over other monoamine transporters, thereby minimising the side effects observed in the older generation of tricyclic antidepressants. Selective serotonin reuptake inhibitors (SSRIs) have shown to be among the most effective treatment of depression currently available. However they are known to have several considerable disadvantages over other classes of antidepressant drugs, such as a slow onset of action (often taking several weeks), headaches, nausea and sleep disruption. With this in mind researchers are constantly trying to improve the profile of compounds used to treat depression. The main aim of this thesis is to design, synthesise and biochemically test a series of novel compounds in the search for a selective SERT inhibitor, from which further work in derivatising the most active skeletal structure may proceed. In chapter one the biochemical nature of depression and neurotransmission, including the role played by the serotonin transporter, with the main focus being the monoamine theory of depression is discussed. A comprehensive range of compounds active at SERT is reviewed based on the biochemical activities imparted by the various structural properties of the ligands. Attention is also drawn to the studies carried out on the proposed active binding sites within SERT and the computational models produced as a result.
dc.format1 volume
dc.language.isoen
dc.publisherTrinity College (Dublin, Ireland). School of Pharmacy & Pharmaceutical Sciences
dc.relation.isversionofhttp://stella.catalogue.tcd.ie/iii/encore/record/C__Rb12411757
dc.subjectPharmaceutical Chemistry, Ph.D.
dc.subjectPh.D. Trinity College Dublin
dc.titleStudies in the design and synthesis of novel selective serotonin reuptake inhibitors
dc.typethesis
dc.type.supercollectionthesis_dissertations
dc.type.supercollectionrefereed_publications
dc.type.qualificationlevelDoctoral
dc.type.qualificationnameDoctor of Philosophy (Ph.D.)
dc.rights.ecaccessrightsopenAccess
dc.format.extentpaginationpp 330
dc.description.noteTARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record